SCHEMBL4877906

SCHEMBL4877906

CNc1ncc(-c2nccc(Nc3cc(NC(=O)c4ccnc(C(C)(C)C#N)c4)ccc3C)n2)cn1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 20/20 0.52
BRAF P15056 16/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4631512 0.91 BRAF (0.57) RAF1BRAF
SCHEMBL4878345 0.90 RAF1 (0.53) RAF1BRAF
SCHEMBL4886254 0.88 MAPK14 (0.47) RAF1BRAF
SCHEMBL4882776 0.82 BRAF (0.57) RAF1BRAF
SCHEMBL4631343 0.81 BRAF (0.58) RAF1BRAF
SCHEMBL30237033 0.77 RAF1 (0.59) RAF1BRAF
SCHEMBL29272141 0.77 RAF1 (0.59) RAF1BRAF
SCHEMBL19328020 0.76 RAF1 (0.60) RAF1BRAF
SCHEMBL4877170 0.76 BRAF (0.63) RAF1BRAF
SCHEMBL25988162 0.74 RAF1 (0.60) RAF1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080146570-A1 Chemical Compounds ASTRAZENECA AB (SE) 2008-06-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080146570-A1 Chemical Compounds BRAF, RAF1, NRAS RAF1 2/4885BRAF 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.